Protective Effect of a Bispecific Fc-Fusion Protein on the Barrier of Human Retinal Pigment Epithelial Cells
- 5 February 2021
- journal article
- research article
- Published by S. Karger AG in Ophthalmic Research
- Vol. 64 (4), 656-663
- https://doi.org/10.1159/000515053
Abstract
Introduction: The aim of the study was to evaluate the protective effects of IBI302, a bispecific Fc-fusion protein that theoretically can bind vascular endothelial growth factor (VEGF), complement C3b, and C4b in the barrier of the cultured human retinal pigment epithelial (hRPE) cells. Methods: Primary hRPE cells were isolated and cultured to monolayer barrier. hRPE monolayers were divided into the PBS control group, VEGF-Trap group, complement receptor 1 (CR1) group, and IBI302 group. Identification of hRPE cells, barrier function, inflammation factors, and immune response products was tested by immunofluorescent staining, transepithelial resistance (TER), and ELISA. Results: IBI302 treatment significantly improved the TER of the barrier of hRPE cells after complement-activated oxidative stress compared with the PBS control group, VEGF-Trap group, and CR1 group. The maximum effect of IBI302 on protecting hRPE cell viability was observed at the concentration of 1 μg/mL. The elevated expression of VEGF, chemokine (C-C Motif) ligand 2, C3a, C5a, and membrane attack complex was reduced by IBI302. Conclusion: IBI302 could protect the barrier function of hRPE cells. IBI302 might be a potentially effective drug for the RPE barrier-associated ocular diseases.Keywords
This publication has 36 references indexed in Scilit:
- Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degenerationAutophagy, 2013
- Relationship between Complement Membrane Attack Complex, Chemokine (C-C Motif) Ligand 2 (CCL2) and Vascular Endothelial Growth Factor in Mouse Model of Laser-induced Choroidal NeovascularizationOnline Journal of Public Health Informatics, 2011
- Therapeutic targets in age-related macular diseaseJCI Insight, 2010
- Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidalSalmonellaby blood cells in AfricansProceedings of the National Academy of Sciences of the United States of America, 2010
- Oxidative Stress Renders Retinal Pigment Epithelial Cells Susceptible to Complement-mediated InjuryOnline Journal of Public Health Informatics, 2009
- Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinoloneBritish Journal of Ophthalmology, 2009
- Oxidative stress promotes ocular neovascularizationJournal of Cellular Physiology, 2009
- The Aged Retinal Pigment Epithelium/Choroid: A Potential Substratum for the Pathogenesis of Age-Related Macular DegenerationPLOS ONE, 2008
- VEGF modulation of retinal pigment epithelium resistanceExperimental Eye Research, 2007
- Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restrictionThe Journal of Experimental Medicine, 2006